William Bill Wells

2009

In 2009, William Bill Wells earned a total compensation of $3.7M as Chief Executive Officer and President, BLS at Valeant Pharmaceuticals International, a 15% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,289,484
Option Awards$102,421
Salary$860,085
Stock Awards$1,329,531
Other$107,686
Total$3,689,207

Wells received $1.3M in stock awards, accounting for 36% of the total pay in 2009.

Wells also received $1.3M in non-equity incentive plan, $102.4K in option awards, $860.1K in salary and $107.7K in other compensation.

Rankings

In 2009, William Bill Wells' compensation ranked 1,166th out of 9,885 executives tracked by ExecPay. In other words, Wells earned more than 88.2% of executives.

ClassificationRankingPercentile
All
1,166
out of 9,885
88th
Division
Manufacturing
409
out of 3,690
89th
Major group
Chemicals And Allied Products
87
out of 871
90th
Industry group
Drugs
58
out of 643
91st
Industry
Pharmaceutical Preparations
51
out of 446
89th
Source: SEC filing on April 21, 2010.

Wells' colleagues

We found six more compensation records of executives who worked with William Bill Wells at Valeant Pharmaceuticals International in 2009.

2009

William Wells

Valeant Pharmaceuticals International

Chief Executive Officer

2009

Gilbert Godin

Valeant Pharmaceuticals International

Chief Operating Officer

2009

Christian Fibiger

Valeant Pharmaceuticals International

Chief Scientific Officer

2009

Gregory Gubitz

Valeant Pharmaceuticals International

General Counsel

2009

Margaret Mulligan

Valeant Pharmaceuticals International

Chief Financial Officer

2009

Mark Durham

Valeant Pharmaceuticals International

Senior Vice President, Human Resources

You may also like